★ Annual Review 2027 tickets now on sale Get your tickets →

News/Compliance & Enforcement/Johnson & Johnson Subsidiary Pays $9.75M to Settle Qui Tam Whistleblower Lawsuit over Alleged Violations of the Anti-Kickback Statute and False Claims Act
Expert Opinion·Compliance & Enforcement Brief

Johnson & Johnson Subsidiary Pays $9.75M to Settle Qui Tam Whistleblower Lawsuit over Alleged Violations of the Anti-Kickback Statute and False Claims Act

Johnson & Johnson orthopedics and neurosurgery medical device unit DePuy Synthes has agreed to pay $9.75 million to resolve allegations it violated the Anti-Kickback Statute and False Claims Act by providing in-kind kickbacks to an orthopedic surgeon as an incentive for using its products.

🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.
Not ready to join? Take the free Pub K Weekly digest.One email. Free. Top industry articles, the community calendar, and the latest job postings.